42
DAFTAR PUSTAKA
Alberti SG & Zimmet P. 2006. The IDF Consensus Worldwide Definition of The
Metabolic Syndrome. Available from :
http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf [Accesed 23 May 2014]
Alvina. 2009. Hepatic Enzyme Concentrations as Indicators of Nonalcoholic Fatty Liver Disease. Univ Med 28(3) : 133-204
Alvina. 2010. Hepatic Type IV Collagen as Marker of Fibrosis in Non Alcoholic Fatty Liver Disease. Univ Med 29(2) : 114-124
Alwahsh, SM et al. 2014. Diet High in Fructose Leads to an Overexpression of Lipocalin-2 In Rat Fatty Liver. World J Gastroenterol 20 (7) : 1807-1821.
Amarapurkar, Deepak. 2011. NAFLD and NASH: Asian Perspective. Tropical Gastroenterology S : 23–26.
Arciello, M et al. 2013. Environmental Pollution: A Tangible Risk forNAFLD Pathogenesis. Int. J. Mol. Sci 14 : 22052-22066.
Berardis S & Sokal E. 2014. Pediatric Non-alcoholic Fatty Liver Disease: an
Increasing Public Health Issue. Eur J Pediatr 173: 131–139.
43
Chalasani N, et al. 2012. AASLD practice guidelines: The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the AmericanGastroenterological Association. Hepatology 55 : 2005-2023.
Durazzo, M et al. 2014. Gender Spesific Medicine in Liver Disease : A point of View. World J Gastroenterol 20 (9) : 2127-2135
Erickson SK. 2009. Nonalcoholic Fatty Liver Disease. Journal of Lipid Research
April Supplement
Florentino et al. 2013. Nonalcoholic Fatty Liver Disease in Menopausal Women.
Arq Gastroenterol 50 (3)
Fruci B, Giuliano S, Mazza A, Malaguarnera R, Belfiore A. 2013. Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment. Int. J. Mol. Sci.14 : 22933-22966
Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. 2013. Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease. Nutrients5 : 1544-1560
Kanuri G & Bergheim I. 2013. In Vitro and in Vivo Models of Non Alcoholic Fatty Liver Disease (NAFLD). Int. J. Mol. Sci 14 : 11963-11980
44
Kebapcilar L, Bilgir O, Cetinkaya E, Akyol M, Bilgir F, Bozkaya G. 2010. The Effect of Helicobacter Pylori Eradication on Macrophage Migration Inhibitory Factor, C-Reactive Protein and Fetuin-a Levels. Clinics (Sao Paulo) 65 : 799-802
Lankarani KB. 2013. Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study. Hepat Mon. 13 (5) : e9248
Latea L, Negrea S, Bolboaca S. 2013. Primary Non-alcoholic Fatty Liver Disease in Hypertensive Patients. Australasian Medical Journal (AMJ) 6 (6) 325-330
Li Meng, Shen Zhe, Li You-Ming. 2013. Potential Role of Helicobacter Pylori Infection in Nonalcoholic Fatty liver disease. World J Gastroenterol 19 (41) : 7024-7031
Liao Xian-Hua, Cao Xu, Liu Jie, Xie Xiao-Hua, Sun Yan-Hong, Zhong Bi-Hui. 2013. Prevalence and features of fatty liver detected by physical examination in Guangzhou. World J Gastroenterol 19 (32) : 5334-5339
Liu, W.Y et al. 2014. Effect of Aerobic Exercise and Low Carbohydrate Diet on Pre-diabetic Non-alcoholic Fatty Liver Disease in Postmenopausal Women and Middle Aged Men – The Role of Gut Microbiota Composition: Study Protocol for the AELC randomized controlled trial. BMC Public Health 14 : 48
Manolakis AC, et al. 2011. Increased fetuin A Levels in Helicobacter Pylori Infection: a Missing Link Between H. pylori and insulin resistance?
45
Mofrad et al. 2003. Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal ALT Values. Hepatology 37 (6)
Moon JS, Yoon JS, Won KC, Lee HW. 2013. The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease. Diabetes Metab J 37: 278-285
O Al-Jiffri, FM Al-Sharif, SM Abd El-Kader, EM Ashmawy. 2013. Weight Reduction Improves Markers of Hepatic Function and Insulin Resistance in Type-2 Diabetic Patients With Non-alcoholic Fatty liver. African Health Science (13)
Patell R, Dosi R, Harshal J, Shet S, Shah P, Jasdanwala S. 2014. Non-Alcoholic Fatty Liver disease (NAFLD) in Obesity. Journal of Clinical and Diagnostic Research 8(1) : 62-66
Qu Z, Zhu Y, Jiang J, Shi Y, Chen Z. 2013. The Clinical Characteristic And Etiological Study of Nonalcoholic Fatty Liver Disease in Chinese Women With PCOS. Iran J Reprod Med 11(9) : 725-732
Ratnasari N, Senorita H, Adie R H, Bayupurnama P, Maduseno S, Nurdjanah S. 2012. Non AlcoholicFatty Liver Disease Related to Metabolic Syndrome: A Case Control Study. Yogyakarta : The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy 13 (1)
46
Sari, G. 2012. Penyakit Perlemakan Hati Non-Alkoholik PadaSindroma Metabolik Dewasa. Jurnal Media Medika Muda
Schwenger K & Allard J. 2014. Clinical Approaches to Non-Alcoholic Fatty Liver Disease. World J Gastroenterol 20(7): 1712-1723
Seo, et al. 2013. Low Vitamin D Status Is Associated with Nonalcoholic Fatty Liver Disease Independent of Visceral Obesity in Korean Adults. PLoS ONE 8(10) : e75197
Trojak, et al. 2013. Nonalcoholic Fatty Liver Disease is Associated With Low HDL Cholesterol and Coronary Angioplasty in Patients With Type 2 Diabetes. Med Sci Monit 19: 1167-1172
Wang Y, Li Y Y, Nie Y Q, Zhou Y J, Cao C Y, Xu L. 2013. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Experimental And Therapeutic Medicine 6: 77-84
Wong JR &Ahmed A. 2014. Obesity And Non-Alcoholic Fatty Liver Disease: Disparate Associations Among Asian Populations. World J Hepatol 6 (5) : 263-273
